annb0t
Top 20
Revenue: $1.28 billion, an increase of 10% year-over-year. Gross Margin: Increased by 230 basis points to 59.2%. Net Income: Increased by 29%. Non-GAAP Earnings Per Share: Increased by 29%. Device Sales Growth: 11% globally on a constant currency basis. Masks and Accessories Sales Growth: 11% globally on a constant currency basis. SG&A Expenses: Increased by 9%, representing 18.8% of revenue. R&D Expenses: Increased by 10%, representing 6.3% of revenue. Cash Flow from Operations: $309 million. C...
>>> Read more: ResMed Inc (RMD) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
>>> Read more: ResMed Inc (RMD) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
